A Phase I, Open-Label, Parallel-Group, Two-Part Study to Evaluate the Pharmacokinetics and Safety of GSK2336805 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects (HAI117380)
Phase of Trial: Phase I
Latest Information Update: 19 May 2017
At a glance
- Drugs JNJ 56914845 (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 28 Mar 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
- 14 Mar 2014 Status changed from recruiting to active, no longer recruiting, as per ClinicalTrials.gov record.
- 02 May 2013 Planned initiation date changed from 1 Apr 2013 to 1 May 2013 as reported by ClinicalTrials.gov.